Responses

Download PDFPDF

Daily versus as-needed inhaled corticosteroid for mild persistent asthma (The Helsinki early intervention childhood asthma study)
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

  • Published on:
    Use of approriate inhaler devices for optimal delivery of inhaled corticosteroids

    We thank Dr Sonnappa and Dr Turner for their correct criticism about the use of inhaler devices for optimal delivery of inhaled corticosteroids. Concerning the present study, we would like to point out that dry powder inhalers were used for the inhaled corticosteroid and the beta-2-agonist according to the present guidelines. In order to achieve adequate teatment compliance, disodium cromoglycate was used as pressurised...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Appropriate inhaler devices for children with asthma

    Samatha Sonnappa brought out an important question about the use of appropriate inhaler devices in the treatment of asthma. In the present study in children 5-10 years of age we have solely used dry powder inhalers. The guidelines presented by Sonappa are the common recommendations in Finland as well: pressurised metered dose inhalers with spacer for children aged 0-5 years; and dry powder inhalers for children over 5 y...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Re: Use of appropriate inhaler devices for optimal delivery of inhaled corticosteroids

    Sir,

    Like Dr Sonnappa in London, I was very disappointed to see a picture on the front of this month’s Archives of a child using a pressurised metered dose inhaler (pMDI) without a spacer. This is the second such picture to appear on the front of Archives within the last 12 months and gives the wrong message to readers. The correct message is that pMDIs should not be used without a spacer device in children....

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Use of appropriate inhaler devices for optimal delivery of inhaled corticosteroids

    The BTS guidelines on the management of asthma clearly state that in children aged 0-5 years, pressurised metered dose inhaler (pMDI) with spacer is the preferred method of delivery of inhaled corticosteroids (ICS); and in children aged 5-12 years and adults, dry powder inhalers (DPI) are as effective as pMDI with spacer (Grade A evidence).(1) The cover illustration of the August issue of the Archives shows a young boy...

    Show More
    Conflict of Interest:
    None declared.